Literature DB >> 15150337

Inhibition of Clostridium difficile strains by intestinal Lactobacillus species.

Paul Naaber1, Imbi Smidt1, Jelena Štšepetova1, Tatjana Brilene1, Heidi Annuk1, Marika Mikelsaar1.   

Abstract

Indigenous intestinal microflora (including lactobacilli) has an important role in protection against Clostridium difficile infection. To assess in vitro interaction between lactobacilli and C. difficile, antagonistic activity of 50 intestinal Lactobacillus spp. strains against 23 pathogenic C. difficile strains was determined. Phenotypic properties of C. difficile strains [production of short-chain fatty acids (SCFAs) and toxin A, and antimicrobial susceptibility] and lactobacilli (production of SCFAs and H(2)O(2)) were investigated. Five lactobacilli (Lactobacillus paracasei and Lactobacillus plantarum species) were antagonistic to all C. difficile strains, 18 were antagonistic to some C. difficile strains and 27 showed no antagonistic activity. This antagonistic activity was strain-specific and seemed to correlate with H(2)O(2) and lactic acid production. C. difficile strains that were more sensitive to lactobacilli (n = 9) usually produced higher toxin levels and more SCFAs, and were more resistant to antibiotics, than strains that were resistant to lactobacilli (n = 14). Compatibility of C. difficile strain properties (resistance to lactobacilli or antibiotics) with intestinal microecological conditions (e.g. presence of antagonistic lactobacilli, concentration of antibiotics) may determine expression of disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150337     DOI: 10.1099/jmm.0.45595-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  24 in total

Review 1.  Epidemiology, pathogenesis, and management of Clostridium difficile infection.

Authors:  Rajaraman Durai
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

2.  Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea.

Authors:  Vijay C Antharam; Eric C Li; Arif Ishmael; Anuj Sharma; Volker Mai; Kenneth H Rand; Gary P Wang
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

Review 3.  Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population.

Authors:  Marika Mikelsaar; Epp Sepp; Jelena Štšepetova; Epp Songisepp; Reet Mändar
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 4.  Optimising gut colonisation resistance against Clostridium difficile infection.

Authors:  S Yuille; W G Mackay; D J Morrison; M C Tedford
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-09       Impact factor: 3.267

5.  Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae.

Authors:  Angela E Reeves; Mark J Koenigsknecht; Ingrid L Bergin; Vincent B Young
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

6.  Lactic acid production by Streptococcus thermophilus alters Clostridium difficile infection and in vitro Toxin A production.

Authors:  Glynis L Kolling; Martin Wu; Cirle A Warren; Evelyn Durmaz; Todd R Klaenhammer; Michael P Timko; Richard L Guerrant
Journal:  Gut Microbes       Date:  2012-08-16

7.  Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile.

Authors:  Melinda A Engevik; Kristen A Engevik; Mary Beth Yacyshyn; Jiang Wang; Daniel J Hassett; Benjamin Darien; Bruce R Yacyshyn; Roger T Worrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-31       Impact factor: 4.052

8.  The Impact of pH on Clostridioides difficile Sporulation and Physiology.

Authors:  Daniela Wetzel; Shonna M McBride
Journal:  Appl Environ Microbiol       Date:  2020-02-03       Impact factor: 4.792

Review 9.  Bio-ecological control of chronic liver disease and encephalopathy.

Authors:  Stig Bengmark
Journal:  Metab Brain Dis       Date:  2008-12-23       Impact factor: 3.584

10.  Prevention and treatment of urinary tract infection with probiotics: Review and research perspective.

Authors:  D Borchert; L Sheridan; A Papatsoris; Z Faruquz; J M Barua; I Junaid; Y Pati; F Chinegwundoh; N Buchholz
Journal:  Indian J Urol       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.